Summary
CVS Health Corporation (CVS) filed an 8-K on August 7, 2019, primarily to report its financial results for the three months ended June 30, 2019. The company issued a press release on August 7, 2019, detailing these quarterly results, which is furnished as an exhibit to this filing. Investors should refer to the press release (Exhibit 99.1) for specific financial performance data, including revenue, earnings, and any forward-looking guidance provided by management for the period. This 8-K filing serves as a notification to the market about the release of these important financial updates. While the 8-K itself does not contain the detailed financial figures, it directs stakeholders to the official press release. Therefore, for a comprehensive understanding of CVS Health's performance during the second quarter of 2019, investors must review the accompanying press release, which contains the substantive financial information.
Key Highlights
- 1CVS Health filed an 8-K on August 7, 2019, to announce its second-quarter 2019 financial results.
- 2The press release containing the detailed Q2 2019 financial results is furnished as Exhibit 99.1.
- 3Investors are directed to the press release for specific financial performance data and operational updates for the quarter ended June 30, 2019.
- 4The filing does not contain the financial results directly but references the official press release for such information.
- 5This report is informational and alerts investors to the release of the company's quarterly earnings announcement.